These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 34768915)
1. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade. Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915 [TBL] [Abstract][Full Text] [Related]
2. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma. Yang Z; Liu H; Song Y; Gao N; Gao P; Hui Y; Li Y; Fan T Int J Mol Med; 2024 Sep; 54(3):. PubMed ID: 38994756 [TBL] [Abstract][Full Text] [Related]
3. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo. Liu X; Song M; Wang P; Zhao R; Chen H; Zhang M; Shi Y; Liu K; Liu F; Yang R; Li E; Bode AM; Dong Z; Lee MH Int J Cancer; 2019 Aug; 145(4):1007-1019. PubMed ID: 30887517 [TBL] [Abstract][Full Text] [Related]
4. Natural Borneol Enhances Paclitaxel-Induced Apoptosis of ESCC Cells by Inactivation of the PI3K/AKT. Meng X; Dong X; Wang W; Yang L; Zhang X; Li Y; Chen T; Ma H; Qi D; Su J J Food Sci; 2018 May; 83(5):1436-1443. PubMed ID: 29660811 [TBL] [Abstract][Full Text] [Related]
5. 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade. Jin H; Park MH; Kim SM Oncol Rep; 2015 Apr; 33(4):2031-6. PubMed ID: 25633416 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of the Akt/FOXM1 Signaling Pathway by Panobinostat Suppresses the Proliferation and Metastasis of Gastric Cancer Cells. Lee NR; Kim DY; Jin H; Meng R; Chae OH; Kim SH; Park BH; Kim SM Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073071 [TBL] [Abstract][Full Text] [Related]
7. Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells. Hu WB; Liu YT; Li J; Wang Y; Sun XZ; Hua MY; Liu XT; Hui BN Toxicol In Vitro; 2024 Aug; 99():105867. PubMed ID: 38848824 [TBL] [Abstract][Full Text] [Related]
8. Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt. Lee HH; Ye S; Li XJ; Lee KB; Park MH; Kim SM Oncol Rep; 2014 Jan; 31(1):183-8. PubMed ID: 24247637 [TBL] [Abstract][Full Text] [Related]
9. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma. Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264 [TBL] [Abstract][Full Text] [Related]
10. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells. Tu Y; Tan F; Zhou J; Pan J Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107 [TBL] [Abstract][Full Text] [Related]
11. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762. Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885 [TBL] [Abstract][Full Text] [Related]
12. Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway. Chang Y; Jia HQ; Xu B; Yang L; Xu YT; Zhang JY; Wang MQ; Yang LX; Song ZC Chem Biol Drug Des; 2024 Jan; 103(1):e14416. PubMed ID: 38093418 [TBL] [Abstract][Full Text] [Related]
13. Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway. Shen Z; Xu L; Li J; Zhang N Med Sci Monit; 2017 May; 23():2096-2103. PubMed ID: 28463955 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway. Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656 [TBL] [Abstract][Full Text] [Related]
15. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer. Sharma R; Yadav V; Jha S; Dighe S; Jain S Carbohydr Polym; 2024 Aug; 338():122196. PubMed ID: 38763723 [TBL] [Abstract][Full Text] [Related]
16. Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway. Lu YX; Chen DL; Wang DS; Chen LZ; Mo HY; Sheng H; Bai L; Wu QN; Yu HE; Xie D; Yun JP; Zeng ZL; Wang F; Ju HQ; Xu RH Cell Death Dis; 2016 Oct; 7(10):e2432. PubMed ID: 27787516 [TBL] [Abstract][Full Text] [Related]
17. Reactive Oxygen Species-Mediated Autophagy by Ursolic Acid Inhibits Growth and Metastasis of Esophageal Cancer Cells. Lee NR; Meng RY; Rah SY; Jin H; Ray N; Kim SH; Park BH; Kim SM Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321911 [TBL] [Abstract][Full Text] [Related]
18. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway. Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162 [TBL] [Abstract][Full Text] [Related]
19. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling. Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720 [TBL] [Abstract][Full Text] [Related]
20. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway. Meng Y; Lin ZM; Ge N; Zhang DL; Huang J; Kong F Am J Chin Med; 2015; 43(7):1471-86. PubMed ID: 26503559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]